Crossref
Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings
Advances in Diabetes & Endocrinology · 2026 · 9 (1)
DOI: 10.13188/2475-5591.1000025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Diabetes & Endocrinology, 2026. Verfasst von S Manjula.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Manjula, S. (2026). Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings. Advances in Diabetes & Endocrinology, 9(1). https://doi.org/10.13188/2475-5591.1000025
Vancouver
Manjula S. Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings. Advances in Diabetes & Endocrinology. 2026;9(1). doi:10.13188/2475-5591.1000025
BibTeX
@article{Manjula2026,
author = {Manjula, S},
title = {Clinician Perspectives on Cardiovascular Risk–Based Use of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes Mellitus in Indian Settings},
journal = {Advances in Diabetes & Endocrinology},
year = {2026},
volume = {9},
number = {1},
doi = {10.13188/2475-5591.1000025}
}
EUVIMED